Univercells

About:

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

Top Investors: Kohlberg Kravis Roberts, Bill & Melinda Gates Foundation, Takeda Ventures, Korea Investment Partners, TCD Capital (ex TheClubDeal)

Description:

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.

Total Funding Amount:

$262M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gosselies, Hainaut, Belgium

Founded Date:

2013-01-01

Founders:

Hugues Bultot, José Castillo

Number of Employees:

251-500

Last Funding Date:

2022-10-19

IPO Status:

Private

Industries: